Alexandre Elabbadi

1.0k total citations
20 papers, 203 citations indexed

About

Alexandre Elabbadi is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Alexandre Elabbadi has authored 20 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Alexandre Elabbadi's work include COVID-19 Clinical Research Studies (5 papers), Respiratory Support and Mechanisms (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Alexandre Elabbadi is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Respiratory Support and Mechanisms (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Alexandre Elabbadi collaborates with scholars based in France, Greece and Guadeloupe. Alexandre Elabbadi's co-authors include Muriel Fartoukh, Guillaume Voiriot, Quentin Philippot, Martin Chalumeau, Carole Elbim, Aude Gibelin, Antoine Parrot, Grigoris Gerotziafas, Matthieu Turpin and Tomas Urbina and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Alexandre Elabbadi

18 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Elabbadi France 7 96 37 35 35 31 20 203
Anissa Atif Mirza India 9 82 0.9× 15 0.4× 53 1.5× 34 1.0× 38 1.2× 41 266
Elżbieta Kalicińska Poland 9 74 0.8× 22 0.6× 29 0.8× 24 0.7× 13 0.4× 18 195
Mark Chappell United States 4 189 2.0× 34 0.9× 80 2.3× 15 0.4× 45 1.5× 4 320
Sebastian Trancă Romania 10 31 0.3× 46 1.2× 12 0.3× 42 1.2× 33 1.1× 22 208
Steven F. Komjathy United States 8 76 0.8× 21 0.6× 38 1.1× 145 4.1× 36 1.2× 11 317
Roshan Kumar Mahat India 10 92 1.0× 8 0.2× 47 1.3× 60 1.7× 45 1.5× 23 276
Roberta Bottino Italy 13 92 1.0× 19 0.5× 54 1.5× 38 1.1× 42 1.4× 32 342
Ranu Baral United Kingdom 7 126 1.3× 24 0.6× 79 2.3× 13 0.4× 21 0.7× 14 269
Guillaume Lano France 8 100 1.0× 12 0.3× 46 1.3× 22 0.6× 107 3.5× 16 310
Cátia Ferreira Portugal 7 87 0.9× 43 1.2× 26 0.7× 18 0.5× 57 1.8× 16 210

Countries citing papers authored by Alexandre Elabbadi

Since Specialization
Citations

This map shows the geographic impact of Alexandre Elabbadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Elabbadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Elabbadi more than expected).

Fields of papers citing papers by Alexandre Elabbadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Elabbadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Elabbadi. The network helps show where Alexandre Elabbadi may publish in the future.

Co-authorship network of co-authors of Alexandre Elabbadi

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Elabbadi. A scholar is included among the top collaborators of Alexandre Elabbadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Elabbadi. Alexandre Elabbadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elabbadi, Alexandre, Armand Mekontso‐Dessap, François Lionnet, et al.. (2025). Combined use of respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in sickle-cell adult patients with acute chest syndrome (The ANTIBIO-STA study): a randomised, controlled, open-label trial. The Lancet Regional Health - Europe. 51. 101234–101234. 2 indexed citations
2.
Elabbadi, Alexandre, et al.. (2025). Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study. BMC Infectious Diseases. 25(1). 627–627. 2 indexed citations
3.
Parrot, Antoine, et al.. (2025). Severe hemoptysis associated with lung cancer in the ICU: recurrence and outcome. Annals of Intensive Care. 15(1). 33–33. 2 indexed citations
4.
Elabbadi, Alexandre, Sébastien Besset, Damien Roux, et al.. (2024). Routes of SARS-Cov2 transmission in the intensive care unit: A multicentric prospective study. Journal of Infection and Public Health. 17(8). 102454–102454. 1 indexed citations
5.
Elabbadi, Alexandre, et al.. (2024). Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France. Journal of Infection. 89(5). 106287–106287. 2 indexed citations
6.
Szychowiak, Piotr, Thierry Boulain, Jean‐François Timsit, et al.. (2023). Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study. Annals of Intensive Care. 13(1). 74–74. 3 indexed citations
7.
Urbina, Tomas, Alexandre Elabbadi, Thomas Chaigneau, et al.. (2022). Impairment of neutrophil functions and homeostasis in COVID-19 patients: association with disease severity. Critical Care. 26(1). 155–155. 28 indexed citations
8.
Elabbadi, Alexandre, Tomas Urbina, Emilio Berti, et al.. (2022). Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients. Critical Care. 26(1). 350–350. 11 indexed citations
9.
Decavèle, Maxens, Antoine Parrot, M. Duruisseaux, et al.. (2022). Diagnosis and prognosis of acute respiratory distress syndrome related to diffuse pneumonic-type adenocarcinoma: a single-center case series study. Journal of Thoracic Disease. 14(8). 2812–2825. 2 indexed citations
10.
Gerotziafas, Grigoris, Patrick Van Dreden, Douglas D. Fraser, et al.. (2022). The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19. SHILAP Revista de lepidopterología. 3(1). 204–218.
11.
Elabbadi, Alexandre, Anne Fajac, Martine Antoine, et al.. (2021). A Severe COVID-19 Pneumonia Revealing a Lepidic Adenocarcinoma: A Diagnostic Challenge during the Pandemic Period. American Journal of Respiratory and Critical Care Medicine. 205(3). 357–359. 1 indexed citations
12.
Elabbadi, Alexandre, et al.. (2021). Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report. BMC Pulmonary Medicine. 21(1). 46–46. 7 indexed citations
13.
Parrot, Antoine, Alexandre Elabbadi, Matthieu Turpin, et al.. (2021). Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion. Annals of Intensive Care. 11(1). 48–48. 11 indexed citations
14.
Elabbadi, Alexandre, Guillaume Voiriot, Anne Tristan, et al.. (2021). Lower respiratory tract infection with <i>Staphylococcus aureus</i> in sickle-cell adult patients with severe acute chest syndrome - the STAPHACS Study. Haematologica. 106(12). 3236–3239. 1 indexed citations
15.
16.
Gerotziafas, Grigoris, Theodoros Ν. Sergentanis, Guillaume Voiriot, et al.. (2021). Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Hämostaseologie.
17.
Elabbadi, Alexandre, Jérémie Pichon, Benoît Visseaux, et al.. (2020). Respiratory virus-associated infections in HIV-infected adults admitted to the intensive care unit for acute respiratory failure: a 6-year bicenter retrospective study (HIV-VIR study). Annals of Intensive Care. 10(1). 123–123. 5 indexed citations
18.
Gerotziafas, Grigoris, Theodoros Ν. Sergentanis, Guillaume Voiriot, et al.. (2020). Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Thrombosis and Haemostasis. 120(12). 1680–1690. 31 indexed citations
19.
Voiriot, Guillaume, Quentin Philippot, Alexandre Elabbadi, et al.. (2019). Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. Journal of Clinical Medicine. 8(6). 786–786. 83 indexed citations
20.
Elabbadi, Alexandre, Charlotte Verdet, Patrick Plésiat, et al.. (2019). An unusual community-acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: Clinical disease and microbiological characteristics. Journal of Microbiology Immunology and Infection. 53(4). 647–651. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anissa Atif Mirza Breakdown of academic impact, for papers by Elżbieta Kalicińska Breakdown of academic impact, for papers by Mark Chappell Breakdown of academic impact, for papers by Sebastian Trancă Breakdown of academic impact, for papers by Steven F. Komjathy Breakdown of academic impact, for papers by Roshan Kumar Mahat Breakdown of academic impact, for papers by Roberta Bottino Breakdown of academic impact, for papers by Ranu Baral Breakdown of academic impact, for papers by Guillaume Lano Breakdown of academic impact, for papers by Cátia Ferreira
Rankless by CCL
2026